Cannon,

I was expecting better results too but I think they are still good enough for approval and the Type II results were actually quite excellent.The Type II will eventually be the moneymaker IMO.That said, I plan (as I always have) to sell SOME shares during the pre PDUFA run up.I will buy them(and more) back, with the calls I own, after approval.I don't feel comfortable with all that money riding on the FDA decision.After two disappointments I don't trust them.

For what it's worth.